Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $333000.0.

  • Krystal Biotech's Other Non-Current Assets rose 6403.94% to $333000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $333000.0, marking a year-over-year increase of 6403.94%. This contributed to the annual value of $231000.0 for FY2024, which is 1216.73% down from last year.
  • As of Q3 2025, Krystal Biotech's Other Non-Current Assets stood at $333000.0, which was up 6403.94% from $197000.0 recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Other Non-Current Assets registered a high of $402000.0 during Q1 2023, and its lowest value of $62000.0 during Q3 2021.
  • Over the past 5 years, Krystal Biotech's median Other Non-Current Assets value was $203000.0 (recorded in 2024), while the average stood at $207315.8.
  • In the last 5 years, Krystal Biotech's Other Non-Current Assets surged by 33783.78% in 2022 and then tumbled by 5578.95% in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Other Non-Current Assets stood at $74000.0 in 2021, then skyrocketed by 337.84% to $324000.0 in 2022, then decreased by 18.83% to $263000.0 in 2023, then fell by 12.17% to $231000.0 in 2024, then soared by 44.16% to $333000.0 in 2025.
  • Its Other Non-Current Assets stands at $333000.0 for Q3 2025, versus $197000.0 for Q2 2025 and $218000.0 for Q1 2025.